BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17412729)

  • 1. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
    Filippatos G; Kremastinos DT
    Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible cardiomyopathy.
    Dhadke SV; Dhadke VN
    J Assoc Physicians India; 2006 Sep; 54():740-1. PubMed ID: 17212027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-receptor blockers in dilated cardiomyopathy].
    Osterziel KJ
    Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta-blockers in cardiac insufficiency. Time to reconsider?].
    Follath F
    Schweiz Med Wochenschr; 1996 May; 126(18):747-9. PubMed ID: 8693298
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis of the use of low-dose beta-adrenergic blocking therapy in idiopathic or ischemic dilated cardiomyopathy.
    Zarembski DG; Nolan PE; Slack MK; Lui CY
    Am J Cardiol; 1996 Jun; 77(14):1247-50. PubMed ID: 8651108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.
    Nonen S; Okamoto H; Fujio Y; Takemoto Y; Yoshiyama M; Hamaguchi T; Matsui Y; Yoshikawa J; Kitabatake A; Azuma J
    Pharmacogenomics J; 2008 Feb; 8(1):78-84. PubMed ID: 17404580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of dilated cardiomyopathy].
    Amosova EN
    Ter Arkh; 1994; 66(3):88-91. PubMed ID: 7911259
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-adrenoblockers in treatment of dilated cardiomyopathy].
    Novikov IuI; Konstantinova EV; Stulova MA
    Klin Med (Mosk); 2006; 84(1):11-6. PubMed ID: 16512388
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefit of long-term treatment with metoprolol in patients with dilated cadiomyopathy receiving enalapril: focus on the pattern of left ventricular diastolic filling.
    Nikitin NP; Alyavi AL; Goloskokova VY
    Cardiovasc Drugs Ther; 1999 May; 13(3):271-3. PubMed ID: 10439891
    [No Abstract]   [Full Text] [Related]  

  • 11. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).
    Domanski M; Coady S; Fleg J; Tian X; Sachdev V
    Am J Cardiol; 2007 May; 99(10):1448-50. PubMed ID: 17493477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic dilated cardiomyopathy.
    Cooke CE
    N Engl J Med; 1995 May; 332(20):1384; author reply 1385-6. PubMed ID: 7715656
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model.
    Arimura T; Sato R; Machida N; Bando H; Zhan DY; Morimoto S; Tanaka R; Yamane Y; Bonne G; Kimura A
    J Am Coll Cardiol; 2010 Apr; 55(14):1503-5. PubMed ID: 20359603
    [No Abstract]   [Full Text] [Related]  

  • 16. Congestive cardiomyopathy: treatment advances. Endomyocardial biopsy, new inotropes, beta-blockade.
    Slack JD; Nasser WK
    Indiana Med; 1986 Feb; 79(2):168-71. PubMed ID: 2869082
    [No Abstract]   [Full Text] [Related]  

  • 17. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?
    Alderman J; Grossman W
    Circulation; 1985 May; 71(5):854-7. PubMed ID: 2859129
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of beta-blockers in dilated cardiomyopathy.
    Waagstein F
    Curr Opin Cardiol; 1995 May; 10(3):322-31. PubMed ID: 7612984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.